Skip to content

Clinical trials

Adenocarcinoma, Mucinous trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma, Mucinous Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20173
20191
20211
20221
20231
20242
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Active, not recruiting3
Completed3
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center5
National Cancer Institute (NCI)2
Andreana Holowatyj, PhD, MSCI1
Apollo Therapeutics Ltd1
Appendix Cancer Pseudomyxoma Peritonei Research Foundation1
Brown University1
City of Hope Medical Center1
Seagen Inc.1
Stony Brook University1
University of California, Irvine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma, Mucinous15
Pseudomyxoma Peritonei4
Appendiceal Neoplasms3
Colorectal Neoplasms3
Ovarian Neoplasms3
Stomach Neoplasms3
Cholangiocarcinoma2
Esophageal Neoplasms2
Nasopharyngeal Carcinoma2
Neoplasm Metastasis2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.